Bath & Body Works, Inc. (NYSE:BBWI) Stock Has Consensus Price Target of $22.13 According to Analysts

Bath & Body Works, Inc. (NYSE:BBWI) has received an average recommendation of “Hold” from the twenty analysts that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, fifteen have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $22.13.

A number of analysts have recently issued reports on BBWI shares. Argus reissued a “hold” rating on shares of Bath & Body Works in a research note on Wednesday, September 16th. BMO Capital Markets initiated coverage on Bath & Body Works in a research note on Tuesday, September 8th. They set a “market perform” rating and a $20.00 target price on the stock. Robert W. Baird dropped their target price on shares of Bath & Body Works from $25.00 to $23.00 and set a “neutral” rating for the company in a research report on Thursday, August 27th. UBS Group cut their target price on shares of Bath & Body Works from $19.00 to $17.00 and set a “neutral” rating for the company in a research note on Thursday, August 27th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Bath & Body Works from $22.00 to $24.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 18th.

Bath & Body Works Stock Down 1.8%

Shares of NYSE BBWI opened at $16.11 on Wednesday. The firm has a market cap of $3.25 billion, a P/E ratio of 4.20, a PEG ratio of 0.82 and a beta of 1.40. Bath & Body Works has a twelve month low of $14.27 and a twelve month high of $27.40. The company has a 50 day moving average of $18.55 and a 200 day moving average of $19.10.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.50 billion. During the same period in the previous year, the company earned $0.30 earnings per share. The firm’s quarterly revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, equities analysts expect that Bath & Body Works will post 2.73 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 4th. Investors of record on Friday, August 21st were given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 5.0%. The ex-dividend date was Friday, August 21st. Bath & Body Works’s payout ratio is currently 20.83%.

Institutional Trading of Bath & Body Works

Institutional investors have recently bought and sold shares of the stock. BlackRock Inc. acquired a new position in shares of Bath & Body Works during the second quarter worth $449,065,000. Geode Capital Management LLC grew its stake in Bath & Body Works by 2.9% during the 4th quarter. Geode Capital Management LLC now owns 3,960,475 shares of the company’s stock worth $79,542,000 after buying an additional 110,602 shares during the last quarter. Vaughan Nelson Investment Management L.P. grew its stake in Bath & Body Works by 33.8% during the 1st quarter. Vaughan Nelson Investment Management L.P. now owns 2,852,040 shares of the company’s stock worth $53,248,000 after buying an additional 719,795 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in Bath & Body Works by 34.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,777,576 shares of the company’s stock valued at $51,857,000 after buying an additional 707,449 shares in the last quarter. Finally, Norges Bank acquired a new position in Bath & Body Works during the 4th quarter valued at about $55,504,000. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailer focused on personal care and home fragrance products. Its portfolio includes body lotions and creams, shower products, fragrances, hand soaps and sanitizers, three-wick candles, wall-plug air fresheners, and other home-fragrance items. The company markets products under the Bath & Body Works brand and regularly introduces seasonal and limited-edition collections.

The company sells its products through a network of company-operated stores, its e-commerce website, and other direct channels.